Vivek Ramaswamy Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 4 hours ago
Vivek Ramaswamy has an estimated net worth of at least $974.0 million*, as of Sept. 17, 2025. They own 53.4 million shares of ROIV stock. They have sold 11.6 million shares of ROIV stock since 2021, for an estimated $119.1 million.
Vivek Ramaswamy $ROIV SEC Form 4 Insider Trading
Vivek Ramaswamy has filed a total of 11 insider trades in $ROIV since 2021. Their most recent trade was a sale of 1.2 million shares, made on Sep 03, 2025. Their largest trade was a sale of 4.0 million shares, made on Feb 22, 2023. We estimate that they now own 53.4 million shares of $ROIV, worth an estimated $854.9 million.
Insider Trading at $ROIV
There have been a total of 173 insider trades reported at $ROIV since 2021, with 4.0 million shares purchased and 139.9 million shares sold. The most active insider traders in $ROIV stock have been Eric Venker, Rakhi Kumar, and Eric Venker. The most recent trade was a purchase of 3,315 shares reported by Matthew Gline (CEO), made on Sep 18, 2025.
History of Insider Stock Trades by Vivek Ramaswamy
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ROIV
|
Sale | 1.2 million | Sep 03, 2025 | Sept. 5, 2025, 5:01 p.m. |
|
ROIV
|
Sale | 385,816 | Sep 05, 2025 | Sept. 5, 2025, 5:01 p.m. |
|
ROIV
|
Sale | 194,933 | Sep 04, 2025 | Sept. 5, 2025, 5:01 p.m. |
|
ROIV
|
Sale | 577,007 | Jun 20, 2025 | June 23, 2025, 11:35 a.m. |
|
ROIV
|
Sale | 565,266 | Jun 18, 2025 | June 23, 2025, 11:35 a.m. |
|
ROIV
|
Sale | 200,800 | Jun 06, 2025 | June 6, 2025, 5:49 p.m. |
|
ROIV
|
Sale | 547,430 | Jun 04, 2025 | June 6, 2025, 5:49 p.m. |
|
ROIV
|
Sale | 273,959 | May 06, 2025 | May 8, 2025, 8:51 p.m. |
|
ROIV
|
Sale | 625,000 | May 07, 2025 | May 8, 2025, 8:51 p.m. |
|
ROIV
|
Sale | 3.0 million | Jan 02, 2024 | Jan. 3, 2024, 5:56 p.m. |
|
ROIV
|
Sale | 4.0 million | Feb 22, 2023 | Feb. 22, 2023, 6:04 p.m. |
$ROIV Executives and Stock Owners with Insider Trades
-
Eric Venker, President & COO
-
Rakhi Kumar, Chief Accounting Officer
-
Eric Venker, Chief Operating Officer
-
Matthew Gline, CEO
-
Mayukh Sukhatme, Pres&Chief Investment Officer
-
Eric Venker, President & Immunovant CEO
-
Richard Pulik, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.